ID
18029
Beschrijving
Study of Rituximab Plus High-Dose Chemotherapy Poor Prognosis Non-Hodgkin's Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00141700
Link
https://clinicaltrials.gov/show/NCT00141700
Trefwoorden
Versies (1)
- 15-10-16 15-10-16 -
Geüploaded op
15 oktober 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Lymphoma, Non-Hodgkin's NCT00141700
Eligibility Lymphoma, Non-Hodgkin's NCT00141700
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Similar models
Eligibility Lymphoma, Non-Hodgkin's NCT00141700
- StudyEvent: Eligibility
C3888518 (UMLS CUI [1,2])
C1512858 (UMLS CUI [2])
C1512431 (UMLS CUI [3])
C1398349 (UMLS CUI [2])
C0079757 (UMLS CUI [3])
C0079744 (UMLS CUI [4])
C1321546 (UMLS CUI [5])
C0334634 (UMLS CUI [6])
C0079741 (UMLS CUI [2])
C0079740 (UMLS CUI [3])
C1512894 (UMLS CUI [4])
C0334634 (UMLS CUI [5])
C0677874 (UMLS CUI [1,2])
C1708063 (UMLS CUI [2,1])
C1521726 (UMLS CUI [2,2])
C1522326 (UMLS CUI [1,2])
C0154728 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
C1522449 (UMLS CUI [3])
C1517560 (UMLS CUI [4])
C0007806 (UMLS CUI [5,1])
C1513916 (UMLS CUI [5,2])
C2986497 (UMLS CUI [1,2])
C0006826 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C3887511 (UMLS CUI [2,2])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])